U.S. Chief District Judge Elizabeth Wolford has set deadlines for briefs in a New York health center's 340B contract pharmacy antitrust lawsuit against four drug companies.

Judge Sets Deadlines for Briefs in 340B Contract Pharmacy Antitrust Suit

A federal district judge in Rochester, N.Y., has given four insulin and diabetes drug manufacturers until Oct. 29 to file a motion to dismiss an upstate New York health center’s lawsuit claiming the manufacturers conspired to stop offering 340B pricing when covered entities use contract pharmacies.

U.S. Chief District Judge Elizabeth Wolford gave the health center, Mosaic Health, until Dec. 17 to file papers opposing the companies’ attempt to scuttle its case. The companies—AstraZeneca, Lilly, Novartis, and Sanofi—have until Jan. 14, 2022, to file any replies to Mosaic’s opposition. Wofford issued the scheduling order setting the October, December, and January deadlines late last month.

A federal district judge in Rochester, N.Y., has given four insulin and diabetes drug manufacturers until Oct. 29 to file a motion to dismiss an upstate New York health center’s lawsuit claiming the manufacturers conspired to stop offering 340B pricing when covered entities use contract pharmacies.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report